Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Roche bets on the RNAi approach for obesity through $1bn Rona deal

Oct 13, 2026, 10:26 AM

Read Full Article → Roche bets on the RNAi approach for obesity through $1bn Rona deal

Roche bets on the RNAi approach for obesity through $1bn Rona deal

Translate article text

Choose a language and wait for the translated text.

Roche now joins a growing list of big pharma and biotech players exploring the RNAi approach’s promise in treating obesity.

Roche bets on the RNAi approach for obesity through $1bn Rona deal | PharmaVoice